-
1Academic Journal
Συγγραφείς: A. A. Ivanova, A. A. Gurazheva, E. S. Mel’nikova, V. N. Maksimov, E. G. Nemcova, А. А. Иванова, А. А. Гуражева, Е. С. Мельникова, В. Н. Максимов, Е. Г. Немцова
Συνεισφορές: The study was carried out with the financial support of the Government of the Novosibirsk region within the framework of the State Budget No. 122031700094-5 of Research Institutе of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences., Исследование выполнено при финансовой поддержке Правительства Новосибирской области в рамках ГЗ № 122031700094-5.
Πηγή: Bulletin of Siberian Medicine; Том 22, № 2 (2023); 39-45 ; Бюллетень сибирской медицины; Том 22, № 2 (2023); 39-45 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2023-22-2
Θεματικοί όροι: неконъюгированная гипербилирубинемия, rs3064744, rs34993780, rs56059937, rs4148323, rs4124874, UGT1A1 gene, unconjugated hyperbilirubinemia, ген UGT1А1
Περιγραφή αρχείου: application/pdf
Relation: https://bulletin.ssmu.ru/jour/article/view/5218/3391; https://bulletin.ssmu.ru/jour/article/view/5218/3414; King D., Armstrong M.J. Overview of Gilbert’s syndrome. Drug Ther. Bull. 2019;57(2):27–31. DOI:10.1136/dtb.2018.000028. PMID: 30709860.; Kringen M.K., Piehler A.P., Grimholt R.M., Opdal M.S., Haug K.B., Urdal P. Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants. PLoS One. 2014;9(2):e90248. DOI:10.1371/journal.pone.0090248.; Maruo Y., D’Addario C., Mori A., Iwai M., Takahashi H., Sato H. et al. Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome. Hum. Genet. 2004;115(6):525–526. DOI:10.1007/s00439-004-1183-x.; Steventon G. Uridine diphosphate glucuronosyltransferase 1A1. Xenobiotica. 2020;50(1):64–76. DOI:10.1080/00498254.2019.1617910.; Gazzin S., Masutti F., Vitek L., Tiribelli C. The molecular basis of jaundice: An old symptom revisited. Liver Int. 2017;37(8):1094–1102. DOI:10.1111/liv.13351.; Udomuksorn W., Elliot D.J., Lewis B.C., Mackenzie P.I., Yoovathaworn K., Miners J.O. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics. 2007;17(12):1017–1029. DOI:10.1097/FPC.0b013e328256b1b6.; Zhou J., Yang C., Zhu W., Chen S., Zeng Y., Wang J. et al. Identification of Genetic Risk Factors for Neonatal Hyperbilirubinemia in Fujian Province, Southeastern China: A Case-Control Study. Biomed. Res. Int. 2018;2018:7803175. DOI:10.1155/2018/7803175.; Bale G., Avanthi U.S., Padaki N.R., Sharma M., Duvvur N.R., Vishnubhotla V.R.K. Incidence and risk of gallstone disease in Gilbert’s syndrome patients in indian population. J. Clin. Exp. Hepatol. 2018;8(4):362–366. DOI:10.1016/j.jceh.2017.12.006.; Sugatani J., Yamakawa K., Yoshinari K., Machida T., Takagi H., Mori M. et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem. Biophys. Res. Commun. 2002;292(2):492– 497. DOI:10.1006/bbrc.2002.6683.; https://bulletin.ssmu.ru/jour/article/view/5218
-
2Academic Journal
Συγγραφείς: L. Yu. Ilchenko, I. G. Fedorov, G. G. Totolyan, A. G. Tsvetkova, E. G. Gavrilenko, K. O. Mironov, I. G. Nikitin
Πηγή: Гепатология и гастроэнтерология, Vol 5, Iss 1, Pp 79-84 (2021)
Θεματικοί όροι: синдром криглера-найяра ii типа, синдром жильбера, неконъюгированная гипербилирубинемия, ген уридин-5'-дифосфат (udp) -глюкуронозилтрансферазы, Diseases of the digestive system. Gastroenterology, RC799-869
Relation: http://hepatogastro.grsmu.by/index.php/journalHandG/article/view/187; https://doaj.org/toc/2616-5546; https://doaj.org/toc/2708-5309; https://doaj.org/article/f20e9c6d19bf40fb8be288a947f0d56a